F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatitis B surface antigen

Page 1 of 1 ( 36 items )
<<
1
>>

1	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 180 \| Download: 309
2	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 162 \| Download: 261
3	Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure 1/6/2025 8:47:57 AM \| Browse: 129 \| Download: 608
4	False occult hepatitis B infection with negative hepatitis B surface antigen while positive hepatitis B envelope antigen: A case report 10/21/2024 7:03:24 AM \| Browse: 127 \| Download: 971
5	Immunoprophylaxis failure and vaccine response in infants born to mothers with chronic hepatitis B infection in Djibouti 7/26/2024 10:33:30 AM \| Browse: 205 \| Download: 1256
6	Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer 3/27/2023 2:19:30 PM \| Browse: 390 \| Download: 1371
7	Chronic hepatitis B: New potential therapeutic drugs target 1/15/2022 7:06:22 AM \| Browse: 577 \| Download: 1278
8	Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families 9/29/2021 11:12:00 AM \| Browse: 725 \| Download: 2033
9	Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis 9/22/2021 8:09:41 AM \| Browse: 771 \| Download: 1779
10	Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment 7/21/2021 8:24:09 AM \| Browse: 581 \| Download: 2186
11	Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach 6/18/2021 5:06:16 AM \| Browse: 557 \| Download: 1623
12	Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleoside analogues in hepatitis B e antigen-negative patients 11/24/2020 12:41:22 PM \| Browse: 787 \| Download: 2268
13	Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations 9/17/2020 1:56:14 AM \| Browse: 820 \| Download: 2452
14	Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA 9/27/2018 9:38:46 AM \| Browse: 1202 \| Download: 1858
15	Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy 2/6/2018 3:22:41 AM \| Browse: 1319 \| Download: 2471
16	miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma 7/7/2017 11:41:16 AM \| Browse: 1399 \| Download: 1833
17	Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 3/28/2017 10:34:00 AM \| Browse: 1336 \| Download: 1710
18	Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015 12/6/2016 8:33:00 AM \| Browse: 1241 \| Download: 2643
19	Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study 11/26/2016 6:56:00 PM \| Browse: 1467 \| Download: 2395
20	Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial 5/12/2016 10:38:00 AM \| Browse: 1448 \| Download: 2606
21	Genetic variation of occult hepatitis B virus infection 3/28/2016 3:05:00 PM \| Browse: 1257 \| Download: 2053
22	Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma 3/23/2016 4:26:00 PM \| Browse: 1485 \| Download: 2396
23	Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited 3/11/2016 9:54:00 AM \| Browse: 1561 \| Download: 2390
24	Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients 7/30/2015 11:19:00 AM \| Browse: 1021 \| Download: 2359
25	Seroepidemiology of hepatitis B virus infection and impact of vaccination 7/8/2015 12:00:00 PM \| Browse: 1380 \| Download: 2907
26	Induced immunity against hepatitis B virus 6/29/2015 5:40:00 PM \| Browse: 1077 \| Download: 2268
27	Applications of human hepatitis B virus preS domain in bio- and nanotechnology 6/29/2015 4:40:00 PM \| Browse: 1486 \| Download: 2353
28	Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification 5/1/2015 7:01:00 PM \| Browse: 1493 \| Download: 2246
29	Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity 2/11/2015 5:56:00 PM \| Browse: 1379 \| Download: 1860
30	Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion 1/18/2015 4:09:00 PM \| Browse: 1413 \| Download: 1714
31	Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt 9/12/2014 8:40:00 PM \| Browse: 1243 \| Download: 1489
32	HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions 8/29/2014 11:31:00 AM \| Browse: 1263 \| Download: 1555
33	Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma 8/28/2014 3:52:00 PM \| Browse: 1203 \| Download: 1624
34	Association between metabolic factors and chronic hepatitis B virus infection 8/26/2014 2:46:00 PM \| Browse: 1392 \| Download: 1655
35	Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues 8/26/2014 1:51:00 PM \| Browse: 1159 \| Download: 1617
36	Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients 8/26/2014 11:43:00 AM \| Browse: 1131 \| Download: 1405

Page 1 of 1 ( 36 items )
<<
1
>>

1	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 180 \| Download: 309
2	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 162 \| Download: 261
3	Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure 1/6/2025 8:47:57 AM \| Browse: 129 \| Download: 608
4	False occult hepatitis B infection with negative hepatitis B surface antigen while positive hepatitis B envelope antigen: A case report 10/21/2024 7:03:24 AM \| Browse: 127 \| Download: 971
5	Immunoprophylaxis failure and vaccine response in infants born to mothers with chronic hepatitis B infection in Djibouti 7/26/2024 10:33:30 AM \| Browse: 205 \| Download: 1256
6	Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer 3/27/2023 2:19:30 PM \| Browse: 390 \| Download: 1371
7	Chronic hepatitis B: New potential therapeutic drugs target 1/15/2022 7:06:22 AM \| Browse: 577 \| Download: 1278
8	Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families 9/29/2021 11:12:00 AM \| Browse: 725 \| Download: 2033
9	Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis 9/22/2021 8:09:41 AM \| Browse: 771 \| Download: 1779
10	Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment 7/21/2021 8:24:09 AM \| Browse: 581 \| Download: 2186
11	Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach 6/18/2021 5:06:16 AM \| Browse: 557 \| Download: 1623
12	Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleoside analogues in hepatitis B e antigen-negative patients 11/24/2020 12:41:22 PM \| Browse: 787 \| Download: 2268
13	Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations 9/17/2020 1:56:14 AM \| Browse: 820 \| Download: 2452
14	Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA 9/27/2018 9:38:46 AM \| Browse: 1202 \| Download: 1858
15	Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy 2/6/2018 3:22:41 AM \| Browse: 1319 \| Download: 2471
16	miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma 7/7/2017 11:41:16 AM \| Browse: 1399 \| Download: 1833
17	Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 3/28/2017 10:34:00 AM \| Browse: 1336 \| Download: 1710
18	Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015 12/6/2016 8:33:00 AM \| Browse: 1241 \| Download: 2643
19	Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study 11/26/2016 6:56:00 PM \| Browse: 1467 \| Download: 2395
20	Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial 5/12/2016 10:38:00 AM \| Browse: 1448 \| Download: 2606
21	Genetic variation of occult hepatitis B virus infection 3/28/2016 3:05:00 PM \| Browse: 1257 \| Download: 2053
22	Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma 3/23/2016 4:26:00 PM \| Browse: 1485 \| Download: 2396
23	Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited 3/11/2016 9:54:00 AM \| Browse: 1561 \| Download: 2390
24	Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients 7/30/2015 11:19:00 AM \| Browse: 1021 \| Download: 2359
25	Seroepidemiology of hepatitis B virus infection and impact of vaccination 7/8/2015 12:00:00 PM \| Browse: 1380 \| Download: 2907
26	Induced immunity against hepatitis B virus 6/29/2015 5:40:00 PM \| Browse: 1077 \| Download: 2268
27	Applications of human hepatitis B virus preS domain in bio- and nanotechnology 6/29/2015 4:40:00 PM \| Browse: 1486 \| Download: 2353
28	Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification 5/1/2015 7:01:00 PM \| Browse: 1493 \| Download: 2246
29	Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity 2/11/2015 5:56:00 PM \| Browse: 1379 \| Download: 1860
30	Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion 1/18/2015 4:09:00 PM \| Browse: 1413 \| Download: 1714
31	Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt 9/12/2014 8:40:00 PM \| Browse: 1243 \| Download: 1489
32	HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions 8/29/2014 11:31:00 AM \| Browse: 1263 \| Download: 1555
33	Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma 8/28/2014 3:52:00 PM \| Browse: 1203 \| Download: 1624
34	Association between metabolic factors and chronic hepatitis B virus infection 8/26/2014 2:46:00 PM \| Browse: 1392 \| Download: 1655
35	Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues 8/26/2014 1:51:00 PM \| Browse: 1159 \| Download: 1617
36	Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients 8/26/2014 11:43:00 AM \| Browse: 1131 \| Download: 1405